Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cliborole ointment plus desonide cream sequential therapy versus desonide alone in mild to moderate atopic dermatitis
ChiCTR2100053644Phase 4Recruiting
- Sponsor
- The University of Hong Kong-Shenzhen Hospital
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of desonide and crisaborole in atopic dermatitis (AD) (2 arms), sponsored by The University of Hong Kong-Shenzhen Hospital. Primary endpoints: Eczema Area and Severity Index at Day 29, Body surface area at Day 29 and 2 more. Started Dec 2021; status: recruiting.
02
Drugs
desonidecrisaborole
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2100053644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053644.